ENDRA Life Sciences (NDRA) has issued an update.
The Company recently announced a significant shift in its leadership with the resignation of Mr. Michelon and the subsequent appointment of Mr. Tokman. This update, which could impact investor perceptions and the company’s strategic direction, was shared in a press release that does not legally constitute a formal filing but provides important information for those tracking the company’s governance and market activities.
See more data about NDRA stock on TipRanks’ Stock Analysis page.
